New pap smear method could spot cervical cancer earlier in egyptian women

NCT ID NCT07250841

Completed Diagnosis Sponsor: Kasr El Aini Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a liquid-based Pap smear (ThinPrep) to screen 984 Egyptian women aged 25–60 for early signs of cervical cancer during routine gynecology visits. The goal was to see if this method could detect abnormal cells more effectively than standard approaches. Results will show how many women had precancerous changes, helping improve early detection in general clinics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Liquid-based Pap smear (ThinPrep)
What this could lead to: If successful, this could support wider use of liquid-based Pap smears for early cervical cancer detection in routine gynecology clinics.
What could go wrong: This is an observational study, not a treatment trial. It only measures detection rates, not whether screening reduces cancer deaths. Results may not apply outside Egypt.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER (EARLY DETECTION) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer cervical intraepithelial neoplasia dysplasia of cervix Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER (EARLY DETECTION) CERVICAL INTRAEPITHELIAL NEOPLASIA

Contacts and locations

Locations

Kasr Al-Aini Hospital - Cairo University

Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.